Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Mottet

Showing results (151-160 of 214) with videos related to

Pageof 22
Sort By:
Placenta|February 26, 2022
Corrigendum to "Pandemic stress and SARS-CoV-2 infection are associated with pathological changes at the maternal-fetal interface" [Placenta 115 (2021) 37-44]Marie-Eve Brien, Dorothee Bouron-Dal Soglio, Solenn Dal Soglio, et al.
European Urology|November 7, 2017
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another StandardNicolas Mottet, Maria De Santis, Erik Briers, et al.
European Urology|January 13, 2023
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European CountriesSteven MacLennan, Nuno Azevedo, Eilidh Duncan, et al.
European Urology|November 11, 2020
European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate BiopsyAdrian Pilatz, Rajan Veeratterapillay, Konstantinos Dimitropoulos, et al.
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
World Journal of Urology|April 5, 2014
Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication?Thomas Bessede, Pierre Bigot, Jean-Christophe Bernhard, et al.
European Urology|September 5, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate CancerPhilip Cornford, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|January 27, 2018
Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018Henk G van der Poel, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|September 22, 2018
Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91Henk G van der Poel, Roderick C N van den Bergh, Erik Briers, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
Pageof 22

Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
Placenta|February 26, 2022
Corrigendum to "Pandemic stress and SARS-CoV-2 infection are associated with pathological changes at the maternal-fetal interface" [Placenta 115 (2021) 37-44]Marie-Eve Brien, Dorothee Bouron-Dal Soglio, Solenn Dal Soglio, et al.
European Urology|November 7, 2017
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another StandardNicolas Mottet, Maria De Santis, Erik Briers, et al.
European Urology|January 13, 2023
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European CountriesSteven MacLennan, Nuno Azevedo, Eilidh Duncan, et al.
European Urology|November 11, 2020
European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate BiopsyAdrian Pilatz, Rajan Veeratterapillay, Konstantinos Dimitropoulos, et al.
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
World Journal of Urology|April 5, 2014
Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication?Thomas Bessede, Pierre Bigot, Jean-Christophe Bernhard, et al.
European Urology|September 5, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate CancerPhilip Cornford, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|January 27, 2018
Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018Henk G van der Poel, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|September 22, 2018
Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91Henk G van der Poel, Roderick C N van den Bergh, Erik Briers, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
Pageof 22